Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» ublituximab
ublituximab
TG adds a multiple sclerosis string to its bow
TG adds a multiple sclerosis string to its bow
EP Vantage
TG Therapeutics
hematology
ASH2020
ublituximab
MS
multiple sclerosis
Flag link:
3 Biotech Stocks With Major Catalysts Incoming
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Incyte
TG Therapeutics
Cara Therapeutics
CR845
opioids
ublituximab
leukemia
olumiant
rheumatoid arthritis
Flag link:
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Motley Fool
clinical trials
biotech
Summit Therapeutics
DMD
Jounce Therapeutics
JTX-2011
TG Therapeutics
ublituximab
Flag link:
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Flag link:
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
Endpoints
TG Therapeutics
ublituximab
TG-1101
FDA
CLL
Flag link: